title: Differential Vulnerability of CA1 versus CA3 Pyramidal Neurons After Ischemia: Possible Relationship to Sources of Zn2+ Accumulation and Its Entry into and Prolonged Effects on Mitochondria.
abstract: Excitotoxic mechanisms contribute to the degeneration of hippocampal pyramidal neurons after recurrent seizures and brain ischemia. However, susceptibility differs, with CA1 neurons degenerating preferentially after global ischemia and CA3 neurons after limbic seizures. Whereas most studies address contributions of excitotoxic Ca2+entry, it is apparent that Zn2+also contributes, reflecting accumulation in neurons either after synaptic release and entry through postsynaptic channels or upon mobilization from intracellular Zn2+-binding proteins such as metallothionein-III (MT-III). Using mouse hippocampal slices to study acute oxygen glucose deprivation (OGD)-triggered neurodegeneration, we found evidence for early contributions of excitotoxic Ca2+and Zn2+accumulation in both CA1 and CA3, as indicated by the ability of Zn2+chelators or Ca2+entry blockers to delay pyramidal neuronal death in both regions. However, using knock-out animals (of MT-III and vesicular Zn2+transporter, ZnT3) and channel blockers revealed substantial differences in relevant Zn2+sources, with critical contributions of presynaptic release and its permeation through Ca2+- (and Zn2+)-permeable AMPA channels in CA3 and Zn2+mobilization from MT-III predominating in CA1. To assess the consequences of the intracellular Zn2+accumulation, we used OGD exposures slightly shorter than those causing acute neuronal death; under these conditions, cytosolic Zn2+rises persisted for 10-30 min after OGD, followed by recovery over ∼40-60 min. Furthermore, the recovery appeared to be accompanied by mitochondrial Zn2+accumulation (via the mitochondrial Ca2+uniporter MCU) in CA1 but not in CA3 neurons and was markedly diminished in MT-III knock-outs, suggesting that it depended upon Zn2+mobilization from this protein.
  
  
  
  The basis for the differential vulnerabilities of CA1 versus CA3 pyramidal neurons is unclear. The present study of events during and after acute oxygen glucose deprivation highlights a possible important difference, with rapid synaptic entry of Ca2+and Zn2+contributing more in CA3, but with delayed and long-lasting accumulation of Zn2+within mitochondria occurring in CA1 but not CA3 pyramidal neurons. These data may be consistent with observations of prominent mitochondrial dysfunction as a critical early event in the delayed degeneration of CA1 neurons after ischemia and support a hypothesis that mitochondrial Zn2+accumulation in the early reperfusion period may be a critical and targetable upstream event in the injury cascade.
authors.affiliation: Department of Neurology and.
authors.forename: Yuliya V
authors.initials: YV
authors.lastname: Medvedeva
authors.affiliation: Department of Anatomy and Neurobiology, University of California, Irvine, California 92697.
authors.forename: Sung G
authors.initials: SG
authors.lastname: Ji
authors.affiliation: Department of Neurology and.
authors.forename: Hong Z
authors.initials: HZ
authors.lastname: Yin
authors.affiliation: Department of Neurology and jweiss@uci.edu.
authors.forename: John H
authors.identifier: 0000-0001-9323-7813
authors.initials: JH
authors.lastname: Weiss
mesh_terms: D000818:Animals; D056547:CA1 Region, Hippocampal / Q000187:drug effects / Q000378:metabolism*; D056654:CA3 Region, Hippocampal / Q000187:drug effects / Q000378:metabolism*; D015687:Cell Hypoxia / Q000187:drug effects / Q000502:physiology; D005260:Female; D008297:Male; D051379:Mice; D057507:Mice, 129 Strain; D018345:Mice, Knockout; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D009924:Organ Culture Techniques; D017966:Pyramidal Cells / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors; D015032:Zinc / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D015032:Zinc
keywords: CA1 pyramidal neurons; delayed degeneration; hippocampal slice; in vitro ischemia model; mitochondria; oxygen glucose deprivation